Immunosuppressive Agents: all 5,940 studies that test it
Page 6 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesRecruitingNCT05092451Phase 1/2
- Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release FormulationsRecruitingNCT05089604Phase 4
- Second-line Treatment of Primary Autoimmune Hemolytic AnemiaRecruitingNCT05057468Phase 3
- Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone TumorsRecruitingNCT05057130Phase 2/3
- Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCLRecruitingNCT05054426Phase 3
- Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled TrialRecruitingNCT05040464Phase 3
- COAST Therapy in Advanced Solid Tumors and Prostate CancerRecruitingNCT05036226Phase 1/2
- A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeRecruitingNCT05027945Phase 2
- GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor MalignanciesRecruitingNCT05003895Phase 1
- Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation PatientsRecruitingNCT05001074Phase 3
- Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast CancerRecruitingNCT04997993Phase 1
- Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryRecruitingNCT04991025Phase 2
- Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in InfantsRecruitingNCT04987463Phase 2/3
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingNCT04959175Phase 1/2
- Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMMRecruitingNCT04941937Phase 2
- Sirolimus vs Corticosteroids in Treatment of Thyroid Eye DiseaseRecruitingNCT04936854Phase 2
- Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung DiseaseRecruitingNCT04925375Phase 2
- Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular AnomaliesRecruitingNCT04921722Phase 4
- A Model About the Response of Belimumab in SLENot yet recruitingNCT04893161Phase 4
- Methods of T Cell Depletion Trial (MoTD)RecruitingNCT04888741Phase 2
- Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ LeukemiaRecruitingNCT04881240Phase 1
- A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsRecruitingNCT04877288Phase 3
- Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin LymphomaRecruitingNCT04871607Phase 2
- Weekly Sirolimus TherapyRecruitingNCT04861064Phase 2
- Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04825496Phase 1
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerRecruitingNCT04802759Phase 1/2
- Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisRecruitingNCT04799288Phase 1/2
- Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior UveitisRecruitingNCT04798755Phase 3
- Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsRecruitingNCT04797767Phase 1/2
- A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained ProtocolRecruitingNCT04773366Phase 3
- MicroRNA Profiles in Triple Negative Breast CancerRecruitingNCT04771871Phase 2
- Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma PatientsRecruitingNCT04757337Phase 3
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)RecruitingNCT04747912Phase 2
- PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapyRecruitingNCT04745949Phase 2
- Different Immunosuppressive Treatment in iMNRecruitingNCT04745728Phase 3
- Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System LymphomaRecruitingNCT04737889Phase 2
- Sirolimus Treatment Of Patients With SLENot yet recruitingNCT04736953Phase 2
- Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM PathwayNot yet recruitingNCT04736589Phase 3
- Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell LymphomaRecruitingNCT04715217Phase 1/2
- Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT04714827Phase 1/2
- Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema, CRVO, Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana VitrectomyNot yet recruitingNCT04690608Early Phase 1
- IS-free Treg HaploHCTRecruitingNCT04678401Phase 1
- Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic StrokeRecruitingNCT04675762Phase 2
- A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's LymphomaRecruitingNCT04666168Not applicable
- Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell TumorsRecruitingNCT04665076Not applicable
- A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's LymphomaRecruitingNCT04665063Not applicable
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersRecruitingNCT04644016Phase 2
- First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)RecruitingNCT04638790Phase 3
- Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)RecruitingNCT04629144Phase 2
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingNCT04628767Phase 2/3
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaRecruitingNCT04625907Phase 1/2
- GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant CyclophosphamideRecruitingNCT04622956Phase 1/2
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
- Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in ChildrenRecruitingNCT04610125Not applicable
- Sirolimus for Graves' Orbitopathy (GO)Not yet recruitingNCT04598815Phase 2
- Haploidentical HCT for Severe Aplastic AnemiaRecruitingNCT04558736Phase 2
- A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine TabletsRecruitingNCT04550455Phase 4
- Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)RecruitingNCT04520074Phase 3
- Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaRecruitingNCT04508790Phase 2
- Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)RecruitingNCT04485559Phase 1
- Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell LymphomaRecruitingNCT04484506Phase 2
- Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple SclerosisRecruitingNCT04480853Phase 4
- Belatacept in De Novo Heart TransplantationRecruitingNCT04477629Phase 2
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 3
- Early Use of Long-acting Tacrolimus in Lung Transplant RecipientsRecruitingNCT04469842Early Phase 1
- Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid TumorsRecruitingNCT04469530Phase 2
- TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLLRecruitingNCT04453345Phase 2/3
- Sequential Belimumab and T-cell Based Therapy in SLERecruitingNCT04447053Phase 4
- Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageRecruitingNCT04440267Phase 2
- Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant ChemotherapyRecruitingNCT04437160Phase 2
- Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)Not yet recruitingNCT04406870Phase 4
- Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant RecipientsRecruitingNCT04404127Phase 4
- Randomised Evaluation of COVID-19 TherapyRecruitingNCT04381936Phase 3
- Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease ProphylaxisRecruitingNCT04380740Phase 2
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingNCT04375631Phase 1
- CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)RecruitingNCT04318678Phase 1
- Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia PatientsRecruitingNCT04314219Phase 3
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
- Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingNCT04304352Phase 2
- Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialRecruitingNCT04302870Phase 2/3
- Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic AtrophyRecruitingNCT04292080Phase 2
- Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal InsufficiencyRecruitingNCT04240054Phase 2
- Stem Cell Transplantation in Crohn's DiseaseRecruitingNCT04224558Phase 1/2
- High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)RecruitingNCT04221035Phase 3
- Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective StudyRecruitingNCT04207931Phase 4
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNCT04199026Not applicable
- GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)RecruitingNCT04196413Phase 1
- BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)RecruitingNCT04187105Phase 2
- Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)RecruitingNCT04180085Phase 2
- Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)RecruitingNCT04097561Phase 1
- Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted AngiomaRecruitingNCT04056962Phase 2
- Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT04047641Phase 1/2
- Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaRecruitingNCT04002947Phase 2
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant DisordersRecruitingNCT03980769Phase 2
- A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLLRecruitingNCT03980002Phase 2
- Advanced Therapeutics in Rheumatoid Arthritis (RA)RecruitingNCT03976245Phase 4
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)RecruitingNCT03970096Phase 2
- Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated RejectionRecruitingNCT03955172Not applicable
- A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 GangliosidosisRecruitingNCT03952637Phase 1/2
- Belimumab With Rituximab for Primary Membranous NephropathyRecruitingNCT03949855Phase 2